Annual report [Section 13 and 15(d), not S-K Item 405]

NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details)

v3.25.1
NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details) - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Oct. 28, 2021
Backstop Notes | Senior Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Percentage of common stock outstanding, issuable 9.90%   9.90%
Common stock issuable due to grants of RSUs with service only (i.e., time-vesting) conditions      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 1,022,014 1,238,750  
Common stock issuable under the Backstop Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 1,920,007 1,920,007  
Common stock issuable on exercise of private placement warrants      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 54,556 54,556